Lisa Graver

Lisa Graver

Director/Board Member at ALVOTECH

Net worth: 144 444 $ as of 30/04/2024

53 year
Health Technology
Consumer Services
Commercial Services

Profile

Lisa Graver is currently the Chief Executive Officer at Norwich Pharmaceuticals, Inc. and a Director at Alvotech hf.
She is also a Non-Executive Director at Alvotech.
Ms. Graver is the President of Alvogen Pharma US, Inc. and Almaject, Inc. In the past, she served as the Deputy Chief Executive Officer at Alvogen, Inc. from 2013 to 2015.
Ms. Graver was also a Senior Director & VP-Intellectual Property at Actavis, Inc. from 2006 to 2008.
She started her career as an Associate at Kirkland & Ellis LLP.
Ms. Graver completed her undergraduate studies at the University of Lakehead and obtained a graduate degree from Case Western Reserve University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/02/2024 10,582 ( 0.00% ) 144 444 $ 30/04/2024

Lisa Graver active positions

CompaniesPositionStart
ALVOTECH Director/Board Member 16/06/2022
President -
President -
Chief Executive Officer -
Director/Board Member -
All active positions of Lisa Graver

Former positions of Lisa Graver

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2008
Corporate Officer/Principal -
Chief Executive Officer 01/08/2015
See the detail of Lisa Graver's experience

Training of Lisa Graver

Case Western Reserve University School of Law Graduate Degree
University of Lakehead Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lisa Graver's experience

Connections

34

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ALVOTECH

Health Technology

Private companies7

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

See company connections